Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
If you have any interest in pharmaceuticals, then you can “bank” on the fact that you’ll find DrugBank to be a fantastic resource. Of the “molecule-target interaction” variety, DrugBank is different from many of the other databases out there in its emphasis on pharmaceutical data. It contains FDA-approved biotech (protein/peptide) drugs, FDA-approved small molecule drugs, and a large number of experimental drugs. Together, these categories represent over 10,000 entries. As useful as it is to search databases, I always appreciate an option to browse. DrugBank, in fact, gives me (and you!) six such options: browse by drug name, therapeutic category, interacting gene/enzyme, pathway, chemical class, or association (target, enzyme, carrier, or transporter). For each compound, general chemical information is provided in addition to taxonomy, pharmacology, pharmacoeconomics, references, drug interactions, and targets.